Acology Eliminates Major Debt; Looks to Business Expansion

Print
| Source: Acology Inc.

CORONA, Calif., Aug. 01, 2017 (GLOBE NEWSWIRE) -- Acology Inc. (OTCMKTS:ACOL) announced today that they extinguished a large portion of their present debt by retiring the company’s 3rd party conversion note and, for the first time in its’ history, have attained sole-possession of the company. The company now intends to use the leverage gained from reducing this considerable debt to continue with the aggressive projects planned for this year.

Several strategic projects currently in development, including the final negotiations to purchase EZ Health Solutions and expanding into the CBD and cannabis extract market, will become the focus of the expansion. The company’s debt-reduction also advances Acology’s plans to move to the OTC-QB. Plans to purchase new products and pursue ownership rights to various intellectual properties relating to the cannabis and pharmaceutical industries will now move forward. In addition, Acology’s plans for the remainder of 2017 include potential partnerships and investments in and with other companies. These objectives, once attained, would open new avenues for business expansion in both the healthcare and cannabis industries and fulfill the commitment made to investors to make this year the most profitable in history of the company.

Acology’s earnings have remained stable since the beginning of the year and have not been subject to the buffeting that other, similar companies have experienced. Acology management’s continued and growing confidence in the North American market has paid off with sharp earnings increases. There is good reason to believe, based on the analysis of industry experts, that the fluid US federal position towards the cannabis industry is beginning to stabilize and market increases will reflect that confidence.

For investor or sales information please visit Acology Inc. and D&C Distributors online or by phone. The company is located in their production and distribution facility at 1620 Commerce St. Corona, California, 92880.

Acology trades on the OTC under the call letters ACOL. The company’s websites are www.Acologyinc.com for the hospice and palliative care industry and www.themedtainer.com for the recreational and medical marijuana industry. Orders for Acology products can be taken online and by phone. Custom orders are especially welcome.  Please send all inquiries to info@acologyinc.com or call (844) ACOLOGY (844-226-5649). Ask for Jack Rein, National Services Director.  Acology can also be accessed through Twitter and Instagram at @Acologyinc

This press release includes statements that are covered by the Private Securities Litigation Reform Act of 1995. Because such statements deal with future events they are subject to risks and uncertainties and actual results for fiscal year 2016 and beyond could differ materially from the company’s current expectations. Forward-looking statements are identified by such words as “anticipates”, “projects”, “expects”, “planned”, “intends” and “believes” “estimate” “targets” and other similar expressions that indicate trends and future events. It is understood that investment entails risk on the part of the investor and could result in the loss of some or all his or her investment.